Valve-in-valve/valve-in-ring transcatheter mitral valve implantation vs. redo surgical mitral valve replacement for patients with failed bioprosthetic valves or annuloplasty rings: A systematic review and meta-analysis

Xu, Xiufan; Liu, Hong; Gu, Jiaxi; Li, Minghui; Shao, Yongfeng

doi:10.1016/j.heliyon.2023.e16078

Heliyon

2023

DOI: 10.1016/j.heliyon.2023.e16078

|View full text |Cite

Valve-in-valve/valve-in-ring transcatheter mitral valve implantation vs. redo surgical mitral valve replacement for patients with failed bioprosthetic valves or annuloplasty rings: A systematic review and meta-analysis

Xiufan Xu¹,

Hong Liu²,

Jiaxi Gu

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 39 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Yearly Trends and In‐Hospital Outcomes of Patients Undergoing Transcatheter Mitral Valve‐In‐Valve Replacement in Prosthetic Valve Dysfunction

Jamshed,

Gajjar,

Vardar

et al. 2024

Cathet Cardio Intervent

View full text Add to dashboard Cite

IntroductionTranscatheter mitral valve‐in‐valve replacement (TMVR ViV) is becoming a favorable, less invasive procedure among high‐risk patients to manage mitral valve dysfunction. We aimed to investigate the trends of the predictors and outcomes of the procedure.MethodsThe national inpatient sample databases of 2016−2020 were analyzed using STATA 17 software and ICD‐10 codes for TMVR ViV, with stratification for mitral stenosis (MS) or Mitral regurgitation (MR) as etiology for prosthetic valve dysfunction. The primary outcome was inpatient mortality, whereas myocardial infarction and stroke were secondary outcomes.ResultsOver the 5 years, a total of 5233 patients with TMVR ViV were found, exhibiting a yearly increase of procedural volume from 490 in 2016 to 1400 patients in 2020 and decreasing odds for inpatient mortality (aOR 0.74, p = 0.53 in 2017 to aOR: 0.33, p < 0.04 in 2020). Myocardial infarction was significantly lower with TMVR ViV over the years and with similar odds of stroke post‐operatively. There was a decreasing trend of length of stay over the years. Upon stratification, 635 patients were found to have MR with a prosthetic valve (MRPV), and 50 had MS with a prosthetic valve (MSPV). Among those who underwent TMVR ViV, in‐hospital mortality was recorded in 30 (4%) patients of MRPV and 15 (30%) patients of MSPV (p = 0.002), with significantly higher odds for the MSPV group than MRPV.ConclusionThe continued decline in short‐term mortality and length of stay, with the progressive incorporation of more patients, gives real‐world evidence for the safety and efficacy of TMVR ViV. Extended post‐procedure follow‐up studies are required to investigate long‐term procedural benefits and to explore factors causing higher mortality in the MSPV population.

show abstract

Yearly Trends and In‐Hospital Outcomes of Patients Undergoing Transcatheter Mitral Valve‐In‐Valve Replacement in Prosthetic Valve Dysfunction

Jamshed,

Gajjar,

Vardar

et al. 2024

Cathet Cardio Intervent

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Valve-in-valve/valve-in-ring transcatheter mitral valve implantation vs. redo surgical mitral valve replacement for patients with failed bioprosthetic valves or annuloplasty rings: A systematic review and meta-analysis

Cited by 1 publication

References 39 publications

Yearly Trends and In‐Hospital Outcomes of Patients Undergoing Transcatheter Mitral Valve‐In‐Valve Replacement in Prosthetic Valve Dysfunction

Yearly Trends and In‐Hospital Outcomes of Patients Undergoing Transcatheter Mitral Valve‐In‐Valve Replacement in Prosthetic Valve Dysfunction

Contact Info

Product

Resources

About